Sentinel lymph node biopsy in breast cancer: Review on various methodological approaches

Tumori

Volumn 99, Issue 2, 2013, Pages 149-153

  Zengel, Baha ^a   Yararbas, Ulkem ^b   Sirinocak, Ahmet ^a   Ozkok, Guliz ^a   Denecli, Ali Galip ^a   Postaci, Hakan ^a   Uslu, Adam ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Isosulfan blue; Radiocolloid; Sentinel lymph node biopsy

Indexed keywords

CHLORIDE; COLORING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FUCHSINE; ISO SULFAN BLUE; ISO-SULFAN BLUE; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT; RHENIUM; RHENIUM SULFIDE; TECHNETIUM TC 99M NANOCOLLOID;

ADULT; AGED; ARTICLE; AXILLA; BREAST TUMOR; CHI SQUARE DISTRIBUTION; COLLOID; FEMALE; FROZEN SECTION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHI-SQUARE DISTRIBUTION; CHLORIDES; COLLOIDS; COLORING AGENTS; CONTRAST MEDIA; FEMALE; FROZEN SECTIONS; HUMANS; INJECTIONS, INTRADERMAL; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RHENIUM; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

MLCS; MLOWN;

EID: 84881221547     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161309900205     Document Type: Article

References (27)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 220: 391-401, 1994.
2. Haigh PI, Giuliano AE: Sentinel lymphadenectomy in node negative breast cancer. Cancer Treat Res, 103: 25-37, 2000.
3. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernández JR: Sentinel lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol, 7: 983-990, 2006.
4. Motomura K, Egawa C, Komoike Y, Kataoka T, Nagumo S, Koyama H, Inaji H: Sentinel node biopsy for breast cancer: technical aspects and controversies. Breast Cancer, 14: 25-30, 2007.
5. Benson JR, della Rovere GQ: Axilla Management Consensus Group. Management of the axilla in women with breast cancer. Lancet Oncol, 8: 331-348, 2007.
6. Yararbas U, Argon AM, Yeniay L, Kapkac M: Problematic aspects of sentinel lymph node biopsy and its relation to previous excisional biopsy in breast cancer. Clin Nucl Med, 34: 854-858, 2009.
7. Meyer-Rochow GY, Martin RC, Harman CR: Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alone with triple modality localization. ANZ J Surg, 73: 815-818, 2003.
8. Yararbas U, Argon AM, Yeniay L, Zengel B, Kapkaç M: The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer. Nucl Med Biol, 37: 805-810, 2010.
9. Jimenez IR, Roca M, Vega E, García ML, Benitez A, Bajén M, Martín-Comín J: Particle sizes of colloids to be used in sentinel lymph node radiolocalization. Nucl Med Commun, 29: 166-172, 2008.
10. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 349: 546-553, 2003.
11. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, Cerrito PB, Edwards MJ: Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol, 18: 2560-2566, 2000.
12. Kell MR, Burke JP, Barry M, Morrow M: Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat, 120: 441-447, 2010.
13. Krikanova M, Biggar M, Moss D, Poole G: Accuracy of sentinel node biopsy for breast cancer using blue dye alone. Breast J, 16: 384-388, 2010.
14. Cserni G, Rajtár M, Boross G, Sinkó M, Svébis M, Baltás B: Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer. World J Surg, 26: 592-597, 2002.
15. Bines S, Kopkash K, Ali A, Fogg L, Wool N: The use of radioisotope combined with isosulfan blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer. Surgery, 144: 606-610, 2008.
16. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Duez N, Cataliotti L, Klinkenbijl JH, Westenberg HA, van der Mijle H, Snoj M, Hurkmans C, Rutgers EJ: Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol, 17: 1854-1861, 2010.
17. Wilhelm AJ, Mijnhout GS, Franssen EJ: Radiopharmaceuticals in sentinel lymph-node detection - an overview. Eur J Nucl Med, 26 (4 Suppl): S36-42, 1999.
18. Leidenius MH, Leppänen EA, Krogerus LA, Smitten KA: The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer. Nucl Med Commun, 25: 233-238, 2004.
19. Jastrzebski T, Lass P, Swierblewski M, Wydra D, Drucis K, Kruszewski W, Gulida G, Kopacz A: The influence of radioisotope vehicle on breast sentinel node detection. Eur J Surg Oncol, 32: 928-932, 2006.
20. Park C, Seid P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong SP: Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J, 11: 29-33, 2005.
21. Koizumi M, Nomura E, Yamada Y, Takiguchi T, Makita M, Iwase T, Tada T, Tada K, Nishimura S, Takahashi K, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G: Radioguided sentinel node detection in breast cancer patients: comparison of 99mTc phytate and 99mTc rhenium colloid efficacy. Nucl Med Commun, 25: 1031-1037, 2004.
22. Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, Igci A, Yavuz E, Tuzlali S, Muslumanoglu M, Cantez S: Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Clin Nucl Med, 33: 262-267, 2008.
23. Somasundaram SK, Chicken DW, Waddington WA, Bomanji J, Ell PJ, Keshtgar MR: Sentinel node imaging in breast cancer using superficial injections: technical details and observations. Eur J Surg Oncol, 35: 1250-1256, 2009.
24. Viale G, Bosari S, Mazzarol G, Galimberti V, Luini A, Veronesi P, Paganelli G, Bedoni M, Orvieto E: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer, 85: 2433-2438, 1999.
25. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I: A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer, 115: 1555-1562, 2009.
26. Choi YJ, Yun HR, Yoo KE, Kim JH, Nam SJ, Choi YL, Ko YH, Kim BT, Yang JH: Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer. Jpn J Clin Oncol, 36: 489-493, 2006.
27. Carmon M, Olsha O, Rivkin L, Spira RM, Golomb E: Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Breast J, 12: 199-201, 2006.